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Background: Iodine is an essential micronutrient for thyroid hormone production. Adequate iodine intake and
normal thyroid function are important during early development, and breastfed infants rely on maternal iodine
excreted in breast milk for their iodine nutrition. The proportion of women in the United States of childbearing
age with urinary iodine concentration (UIC) <50 lg/L has been increasing, and a subset of lactating women may
have inadequate iodine intake. UIC may also be influenced by environmental exposure to perchlorate and
thiocyanate, competitive inhibitors of iodine transport into thyroid, and lactating mammary glands. Data re-
garding UIC in U.S. lactating women are limited. To adequately assess the iodine sufficiency of lactating
women and potential associations with environmental perchlorate and thiocyanate exposure, we conducted a
multicenter, cross-sectional study of urinary iodine, perchlorate, and thiocyanate concentrations in healthy U.S.
lactating women.
Methods: Lactating women ‡18 years of age were recruited from three U.S. geographic regions: California,
Massachusetts, and Ohio/Illinois from November 2008 to June 2016. Demographic information and multivi-
tamin supplements use were obtained. Iodine, perchlorate, and thiocyanate levels were measured from spot
urine samples. Correlations between urinary iodine, perchlorate, and thiocyanate levels were determined using
Spearman’s rank correlation. Multivariable regression models were used to assess predictors of urinary iodine,
perchlorate, and thiocyanate levels, and UIC <100lg/L.
Results: A total of 376 subjects (‡125 from each geographic region) were included in the final analyses [mean
(SD) age 31.1 (5.6) years, 37% white, 31% black, and 11% Hispanic]. Seventy-seven percent used multivitamin
supplements, 5% reported active cigarette smoking, and 45% were exclusively breastfeeding. Median urinary
iodine, perchlorate, and thiocyanate concentrations were 143lg/L, 3.1lg/L, and 514lg/L, respectively. One-
third of women had UIC <100lg/L. Spot urinary iodine, perchlorate, and thiocyanate levels all significantly
positively correlated to each other. No significant predictors of UIC, UIC <100lg/L, or urinary perchlorate
levels were identified. Smoking, race/ethnicity, and marital status were significant predictors of urinary thio-
cyanate levels.
Conclusion: Lactating women in three U.S. geographic regions are iodine sufficient with an overall median UIC of
143lg/L. Given ubiquitous exposure to perchlorate and thiocyanate, adequate iodine nutrition should be em-
phasized, along with consideration to decrease these exposures in lactating women to protect developing infants.
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Introduction
Iodine is an essential micronutrient necessary for thy-roid hormone production. Adequate iodine intake and
normal thyroid function are especially important during early
development. Breastfed infants rely on maternal iodine ex-
creted in breast milk for the production of thyroid hormones
necessary for normal neurodevelopment (1,2). Therefore,
dietary iodine requirements are higher for lactating women
than they are for nonlactating adults. The U.S. Institute of
Medicine’s Recommended Dietary Allowance for iodine is
290 lg/day for lactating women, compared with 150lg/day
recommended for nonpregnant adults (3).
Since the 1920s, U.S. dietary iodine consumption has been
considered adequate, initially due to the introduction of io-
dized salt. Population iodine sufficiency, based on a sample
size of at least 125 individuals (4), is defined by the World
Health Organization (WHO) as median urinary iodine con-
centrations (UIC) ‡100 lg/L in lactating adults (5). A recent
systematic review of UIC in lactating women based on the
presence of mandatory or voluntary iodine fortification pro-
gram reported the mean or median UIC was >100lg/L in
more than 50% of countries with mandatory iodine fortifi-
cation programs, in contrast to less than 33% of countries
with voluntary iodine fortification programs (6). The U.S. has
never had a mandatory iodine fortification program. Al-
though the UIC of the general population is currently deemed
adequate at 164 lg/L (7), the median UIC in U.S. adults de-
creased by over 50% from the early 1970s to the early 1990s,
according to data from the National Health and Nutrition
Examination Survey (NHANES) (8). Of particular concern
is that the prevalence of UIC <50lg/L among women of
childbearing age increased by almost four-fold, from 4% to
15%, during this period. Among pregnant women in large
U.S. national datasets during 2005–2010, only third-trimester
women were iodine sufficient, while first- and second-
trimester women had median urinary iodine concentrations
that categorized them in the mildly iodine insufficient range
(9). While the overall U.S. adult population remains iodine
sufficient by WHO standards, a subset of lactating women
may have inadequate dietary iodine intake (10).
Sources of iodine in the diet of U.S. adults have been
difficult to identify because there are a wide variety of po-
tential sources, there is a wide amount of variation in the
iodine content of some common foods, and food iodine
content is not listed on packaging. In addition, UIC thresholds
have been identified for populations, but not for individual
patients. For this reason, a public health approach to iodine
supplementation in the United States has been advocated,
particularly for women of childbearing age. The American
Thyroid Association has recommended that all women re-
ceive dietary supplements containing 150lg iodine daily
during preconception, pregnancy, and lactation and that all
prenatal vitamins contain 150 lg of iodine (11). This position
is also supported by the Endocrine Society (12), the Ter-
atology Society (13), and the American Academy of Pedia-
trics (14) but has not yet been widely adopted in current
clinical practice. In the United States, iodine is not a required
component of prenatal vitamins, and a study in 2009 revealed
that only 51% of U.S.-marketed prenatal multivitamins
contain iodine, and the iodine content is often lower than
listed and highly variable (15). In early 2015, the Council for
Responsible Nutrition, the U.S. trade group for supplement
manufacturers, recommended that all manufacturers include
at least 150 lg of iodine per daily dose of supplements in-
tended for pregnant or lactating women (16). However, as
this remains a voluntary measure, there was only a modest
increase to 61% in the proportion of U.S. prenatal vitamins
with iodine in a recent study (17). In a U.S. survey of 275
obstetricians and 199midwives, providers answered that they
at best ‘‘rarely recommended’’ iodine-containing prenatal
multivitamins for women planning pregnancy (68% and
70%, respectively), for pregnant women (66% and 67%), or
for lactating women (68% and 72%) (18).
Urinary iodine content may be influenced by factors other
than maternal dietary iodine intake. The thyroidal effects of
low-level environmental perchlorate and thiocyanate expo-
sures have recently been controversial. In particular, per-
chlorate exposure has been adversely associated with thyroid
dysfunction in some studies. Perchlorate is formed by natural
processes and is a byproduct from airbag inflation systems,
matches, fertilizers, road flares, solid rocket fuel, munitions,
and fireworks (19). Perchlorate is highly soluble and can
persist in groundwater for decades. In the U.S., perchlorate is
ubiquitous and has been detected in food supplies including
baby food, dairy products, eggs, fruits, grains, and vegeta-
bles; in crops such as tobacco; in vitamins (20–25); and in
river water following a July fourth fireworks celebration (26).
It is a competitive inhibitor of the sodium-iodide symporter
(NIS), which actively transports iodine into thyroid and lac-
tating mammary cells (27). When given in pharmacological
doses, perchlorate decreases the active transport of iodine
into the thyroid and possibly breast milk (27). Low-level
environmental perchlorate exposure appears to be ubiquitous
in the U.S. population. In the NHANES 2001–2002 survey,
perchlorate was detected in all 2820 spot urine samples
(median urine perchlorate concentration 3.6 lg/L) (28) and
was a significant negative predictor of total thyroxine and a
positive predictor of thyrotropin values in women, primarily
those with UIC <100lg/L (29). NIS expression is upregu-
lated in the lactating breast and concentrates iodine from the
circulation to a degree similar to the thyroid (30). Given
perchlorate’s high affinity for NIS, breastmilk is a direct
source of perchlorate exposure in the breastfeeding infant.
Cigarette smoke contains cyanide that is metabolized to
thiocyanate, which can also decrease the uptake of iodine into
the thyroid and breastmilk by competitively inhibiting NIS,
although thiocyanate is a less potent NIS competitor than
perchlorate (31). One study in Denmark concluded that cig-
arette smoking decreases breastmilk iodine concentrations
(32), and we demonstrated the same effect in a small cohort
of Boston-area lactating women (33). Cigarette smoke ex-
posure may thus exacerbate the effects of environmental
perchlorate exposure on thyroid function. Thiocyanate is also
naturally present in certain foods, such as cauliflower, broc-
coli, kale, bamboo shoots, and Brussels sprouts.
There are limited data regarding median UICs among U.S.
lactating women. We previously reported that the median
UIC of 56 Boston-area lactating women was 114lg/L (range
25–920 lg/L) (33), similar to that (104lg/L; range 13–
528lg/L) of 97 Boston-area women in the immediate post-
partum period (34). Others have shown that median urinary
iodine levels fluctuate in the immediate postpartum period,
ranging from 36–63 lg/L at 3–10 days after delivery (35).
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However, there is a lack of studies of U.S. lactating women
with a sample size large enough to make an inference re-
garding population level iodine sufficiency. We conducted a
multicenter, cross-sectional observational study of urinary
iodine, perchlorate, and thiocyanate concentrations in 376
healthy lactating U.S. mothers to adequately determine the
iodine sufficiency of this particularly susceptible population
and assess whether this may be associated with low-level
environmental perchlorate and thiocyanate exposures.
Materials and Methods
A multicenter, cross-sectional study of dietary habits and
UIC of 378 lactating women in the U.S. was conducted from
November 2008 through June 2016 (in Massachusetts [MA]
from November 2008 through September 2015; in California
[CA] from March 2011 through June 2016; and in Ohio [OH]
and Illinois [IL] from June 2011 through December 2015).
Institutional ReviewBoard approval for the study was obtained
from the Boston University Medical Campus and Boston
Medical Center (BMC), Boston, MA; University of California
Los Angeles (UCLA) Medical Center, Los Angeles, CA;
University of Southern California, Los Angeles, CA; Ohio
State University (OSU) Medical Center, Columbus, OH; and
NorthShore University Health System, Evanston, IL, where
subject recruitment and urine sample collection occurred.
Study subjects and measures
Breastfeeding women at least 18 years of age were re-
cruited from obstetric and pediatric clinics and through ad-
vertisements in the local community. Women who were
postpartum for any length of time if delivered vaginally or
who were at least two months postpartum if delivered by
cesarean section at BMC were eligible because of the use of
topical iodine-containing cleaners for Foley catheter inser-
tion for cesarean section at BMC. Women who were at least
three weeks postpartum at UCLA and OSU medical centers
were eligible because of the routine use of topical iodine-
containing cleaners at delivery at these sites. The differences
in the duration after birth for eligibility for each site were
partly due to changing information during the course of the
study. Spanish-speaking women at OSU were eligible for
recruitment. Otherwise, non-English speaking women and
women with history of or current known thyroid disease, use
of thyroid hormones or anti-thyroidal medications, or use of
amiodarone within 24 months were excluded. Women who
had undergone radiologic studies with intravenous iodine-
containing contrast agents within three months were also
excluded.
Subject demographic information, including age, race/
ethnicity, marital status, education level, smoking behavior,
present exposure to passive smoke, and any family history of
thyroid disorders was obtained through a questionnaire. Use of
iodine-containing prenatal or other multivitamin supplements
(MVI)was also assessed. However, iodine content ofMVIwas
not known for most subjects, and therefore, we could not dif-
ferentiate iodine-containing and non-iodine-containing MVI.
Spot urine samples were collected from all participants for
measurements of iodine, perchlorate, and thiocyanate.
A total of 378 lactating women from three U.S. geographic
locations were recruited: 126 from Boston, MA; 125 from
Los Angeles, CA; and 127 combined from Columbus, OH
and Evanston, IL. Two participants from IL were unable to
provide urine samples following informed consent, and thus
were excluded from analyses. Therefore, a total of 376 sub-
jects (126 fromMA; 125 from CA; and 125 from OH and IL)
were included in the final analyses. Spot UIC cannot be used
as an individual biomarker of iodine nutritional status due to
its fluctuation from recent iodine intake, andmedian spot UIC
in at least 125 subjects is used instead to assess population
level iodine sufficiency (4).
Laboratory methods
Urine samples were frozen upon collection and stored at
-80C until measurement. Samples from sites outside of
Boston were shipped on dry ice to Boston University Iodine
Research Laboratory for measurements. Levels of spot uri-
nary iodine, perchlorate, and thiocyanate were measured by
ion-chromatography mass spectrometry. The limit of detec-
tion for iodine is 0.5 lg/L, and the interassay coefficient of
variation for iodine measurement in our laboratory is 2.2–
7.6%. The limit of detection for perchlorate is 0.05lg/L, and
the interassay coefficient of variation for perchlorate mea-
surement in our laboratory ranges from 2.2% to 5.9%. The
limit of detection for thiocyanate is 0.05 lg/L, and the in-
terassay coefficient of variation for thiocyanate measurement
in our laboratory is <5%.
Statistical analyses
Descriptive statistics are reported as mean– standard devi-
ation or median (range). Kruskal-Wallis tests and ANOVA
were used to compare characteristics among the three geo-
graphical sites for categorical variables and continuous vari-
ables, respectively. Spearman’s rank correlation was used to
determine univariate associations between urinary perchlorate,
iodine, and thiocyanate. The univariate associations between
urinary perchlorate, iodine, and thiocyanate levels were fur-
ther assessed for only those with urinary iodine concentration
(UIC) less than 100lg/L, the WHO-recommended cutoff for
population level iodine sufficiency in lactating women (5).
Wilcoxon rank sum tests were used to determine univariate
associations between MVI use and urinary iodine levels and
between smoking and urinary thiocyanate levels.
Multivariable linear regression models were used to assess
predictors of urinary iodine, urinary perchlorate, and urinary
thiocyanate levels. Multivariable logistic regression models
were used to assess predictors of UIC <100lg/L. The cov-
ariates included in all multivariable analyses were selected
based on potential biological or clinical significance related
to outcome, and included race/ethnicity, mother’s age, mar-
ital status, highest education level, MVI use, smoking, and
use of formula supplementation for baby. Mother’s age was
entered as a continuous variable in years. The following
were entered as categorical variables; race/ethnicity (white,
black, Latino, Asian, Native American, and others), marital
status (never married, married, divorced, widowed, other),
highest education level (high school or below, vocation/trade
school, two-year college, four-year college, grad school or
higher), MVI use (yes, no), smoking (yes, no). Use of formula
supplementation for baby was categorized in two different
ways: a dichotomous variable of yes/no or a categorical
variable of none/<12 ounces/day/‡12 ounces/day. For as-
sessment of predictors of urinary perchlorate level, urinary
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thiocyanate level was included as a covariate. For assessment
of predictors of urinary thiocyanate level, urinary perchlorate
level was included as a covariate.
All statistical analyses were performed using SAS version
9.3 (SAS institute, Cary, NC). Results were considered sta-
tistically significant if the two-tailed p-value was <0.05.
Results
A total of 376 subjects (125 from CA, 126 from MA, and
125 from OH/IL) were included in the analyses. Demographic
subject characteristics are presented in Table 1. The distribution
of lactating women who were smoking was significantly dif-
ferent among regions, likely because of the difference between
CA and OH/IL (2 and 9 subjects, respectively), although the
overall proportion of women whowere active cigarette smokers
was small. Use ofMVI or supplemental baby formula use when
assessed as yes/no was not significantly different among sites.
The laboratory measurements of spot urinary iodine, per-
chlorate, and thiocyanate levels, as well as the proportions of
women with UIC less than 100lg/L, are presented in Table 2.
Overall median UIC was 143lg/L (range 6–2140lg/L), and
median UICs were not significantly different between geo-
graphic regions (p=0.18). The median UIC in all three regions
Table 1. Subject Characteristics Among Three U.S. Geographic Regions
All (N = 376) CA (N = 125) MA (N = 126)
OH/IL
(N= 125)
Comparison
(p-value)
n (%)
Race/ethnicity <0.001
Non-Hispanic white 137 (37%) 43 (34%) 23 (18%) 71 (29%)
Non-Hispanic black 114 (31%) 13 (10%) 80 (63%) 21 (18%)
Hispanic 39 (11%) 18 (14%) 7 (6%) 14 (12%)
Asian 60 (16%) 45 (36%) 9 (7%) 6 (5%)
Native American 6 (2%) 1 (1%) 5 (4%) 0
Other 15 (4%) 5 (4%) 2 (2%) 8 (7%)
Birthplace <0.001
US 221 (59%) 72 (58%) 53 (42%) 96 (78%)
Other 153 (41%) 53 (42%) 73 (58%) 27 (22%)
Marital status <0.001
Never married 89 (24%) 13 (11%) 48 (38%) 28 (23%)
Married 237 (64%) 74 (60%) 75 (60%) 88 (72%)
Divorced 36 (10%) 32 (26%) 2 (2%) 2 (2%)
Widowed 2 (1%) 1 (1%) 0 1 (1%)
Other 8 (2%) 3 (2%) 1 (1%) 4 (3%)
Highest education <0.001
High school or below 62 (17%) 8 (7%) 24 (19%) 30 (24%)
Vocation/trade school 71 (19%) 26 (21%) 39 (31%) 6 (5%)
2-yr college 42 (11%) 7 (6%) 17 (13%) 18 (15%)
4-yr college 82 (22%) 22 (18%) 23 (18%) 37 (30%)
Grad or higher 114 (31%) 59 (48%) 23 (18%) 32 (26%)
MVI use 0.53
Yes 285 (77%) 99 (80%) 93 (74%) 93 (76%)
No 87 (23%) 25 (20%) 33 (26%) 29 (24%)
Smoking 0.03
Yes 19 (5%) 2 (2%) 6 (5%) 11 (9%)
No 354 (95%) 122 (98%) 120 (95%) 112 (91%)
Use of supplemental baby formula by category 0.04
None 168 (45%) 59 (48%) 48 (38%) 61 (50%)
<12 ounces/day 159 (43%) 56 (45%) 53 (42%) 50 (41%)
‡12 ounces/day 43 (12%) 9 (7%) 24 (19%) 10 (8%)
Dichotomous supplemental baby formula use 0.03
Yes 202 (45%) 65 (52%) 77 (62%) 60 (50%)
No 168 (55%) 59 (48%) 48 (38%) 61 (50%)
Mean (SD) or Median (range)
Mother’s age (years) 31.1 (5.6) 32.7 (5.0) 29.5 (5.8) 31.1 (5.6) <0.001
GA at birth (weeks) 38.6 (2.5) 38.9 (2.4) 39.3 (1.2) 37.6 (3.3) <0.001
Baby age at enrollment (days) 45.5 (6–1868) 49.5 (12–1868) 43.5 (10–672) 44.5 (6–428) <0.001
CA, subjects recruited in California; IL, subjects recruited in Illinois; GA, gestational age; MA, subjects recruited in Massachusetts; MVI,
multivitamin supplements; OH, subjects recruited in Ohio; SD, standard deviation.
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were adequate (159lg/L in CA, 131lg/L in MA, and 154lg/L
in OH/IL), per theWorld Health Organization recommendation
of UIC ‡100lg/L in lactating women (5). There were no sig-
nificant differences of the median urinary iodine, perchlorate, or
thiocyanate levels between regions. There were also no signif-
icant differences in proportion of women with UIC <100lg/L
between regions.
Correlations between spot urinary iodine, perchlorate, and
thiocyanate levels in all subjects, and in subjects with UIC
<100lg/L are presented in Table 3. Spot urinary iodine, per-
chlorate, and thiocyanate levels were all significantly posi-
tively correlated with each other. MVI use and spot UIC were
not significantly correlated ( p = 0.095). Smoking and thio-
cyanate level was significantly positively correlated ( p< 0.001).
Among those with UIC <100lg/L, only perchlorate and io-
dine levels and thiocyanate and iodine levels were signifi-
cantly correlated to each other.
The multivariable models predicting UIC were not statisti-
cally significant (p=0.32, R2=0.054 when supplemental baby
formula use was assessed as a dichotomous variable and
p= 0.24, R2=0.061 when supplemental baby formula use was
assessed as a categorical variable). The multivariable model
predicting UIC <100lg/L was not statistically significant when
supplemental baby formula use was assessed as a dichotomous
variable (p=0.060, R2=0.075). However, the multivariable
model predicting UIC <100lg/L was statistically significant
when supplemental baby formula use was assessed as a cate-
gorical variable (p=0.012, R2=0.094), with race/ethnicity as
the only significant predictor (p=0.02). In thepost hoc subgroup
analyses, Asian race/ethnicity was significantly associated with
0.75 times lower risk of UIC <100lg/L compared with white
race/ethnicity (log estimate -0.287, p=<0.001). The multivari-
able models predicting spot urine perchlorate levels were not
statistically significant (p= 0.30, R2=0.058 when supplemental
baby formula use was assessed as a dichotomous variable and
p=0.30, R2= 0.061 when supplemental baby formula use was
assessed as a categorical variable). The multivariable models
predicting spot urine thiocyanate levels were statistically signif-
icant (Tables 4, 5). When supplemental baby formula use was
assessed as a dichotomous variable, the model was statistically
significant, with p<0.001 and R2=0.22. Among the covariates
assessed, race/ethnicity, marital status, and smoking were sta-
tistically significant predictors (p-values of 0.013, 0.025, and
<0.001, respectively). In the post hoc subgroup analyses,
Table 2. Laboratory Measurements and Comparison of Distribution by Region
All (n= 376) CA (n = 125) MA (n = 126) OH/IL (n = 125)
Comparison
(p-value)
Median (range)
Urinary iodine
concentration (lg/L)
143 (6–2140) 159 (16.9–720) 131 (10.6–595) 154 (6–2140) 0.18
Urinary perchlorate
concentration (lg/L)
3.1 (0.2–94.5) 2.8 (0.2–94.5) 3.2 (0.2–22.4) 3.5 (0.2–31.7) 0.70
Urinary thiocyanate
concentration (lg/L)
514 (12.3–4250) 565 (43.2–2020) 450.8 (31.1–2755) 525.5 (12.3–4250) 0.16
N (%)
UIC <100 lg/L 125 (33%) 37 (30%) 44 (35%) 44 (35%) 0.54
UIC, urinary iodine concentration.
Table 3. Correlations Between Spot Urinary Iodine, Perchlorate, and Thiocyanate Concentrations
All subjects
Iodine Perchlorate Thiocyanate
Iodine ——– Correlation coefficient = 0.284
p< 0.001
Correlation coefficient = 0.364
p < 0.001
Perchlorate Correlation coefficient = 0.284
p < 0.001
——– Correlation coefficient = 0.186
p < 0.001
Thiocyanate Correlation coefficient = 0.364
p < 0.001
Correlation coefficient = 0.186
p< 0.001
——–
Subjects with UIC <100lg/L only
Iodine Perchlorate Thiocyanate
Iodine ——– Correlation coefficient = 0.257
p= 0.004
Correlation coefficient = 0.447
p < 0.001
Perchlorate Correlation coefficient = 0.257
p = 0.004
——– Correlation coefficient = 0.138
p = 0.12
Thiocyanate Correlation coefficient = 0.447
p < 0.001
Correlation coefficient = 0.138
p = 0.12
——–
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black race/ethnicity was significantly associated with lower
thiocyanate level by 213.68lg/L compared with white race/
ethnicity ( p- = 0.001), married status was associated with
lower thiocyanate level by 200.19lg/L compared with never
married status ( p= 0.002), and not smoking was associated
with lower thiocyanate level by 807.08lg/L compared with
smoking ( p < 0.001). When supplemental baby formula use
was assessed as a categorical variable, the model was statis-
tically significant with a p < 0.001 and R2 = 0.22. Among the
covariates assessed, race/ethnicity, marital status, and smok-
ing status were statistically significant ( p-values of 0.013,
0.026, and <0.001, respectively). In the post hoc subgroup
analyses, black race/ethnicity was significantly associated
with lower thiocyanate level by 213.70lg/L compared with
white race/ethnicity ( p= 0.001), married status was associ-
ated with lower thiocyanate level by 199.98lg/L compared
with never married status ( p = 0.002), and not smoking was
associated with lower thiocyanate level by 806.77 lg/L
compared with smoking ( p =<0.001).
Discussion
The data presented here show that U.S. lactating women
from three distinct geographic regions are iodine sufficient,
with an overall median UIC of 143 lg/L, above the WHO
recommended threshold for iodine sufficiency in lactating
women of 100lg/L. The proportion of women with UIC
<100lg/L were similar among all regions, ranging from 30%
to 35%. This is similar to the proportion of U.S. pregnant
women with a UIC <100lg/L in NHANES data (7). Al-
though two-thirds of women were taking aMVI, there was no
correlation betweenMVI use and UIC, althoughmost women
were unsure whether their MVI contained iodine. A recent
study of U.S. prenatal multivitamin supplements showed only
61% contained iodine according to the product labeling (17).
U.S. lactating women are overall iodine sufficient. However,
approximately one-third of our subjects have spot UICs
<100lg/L. The median perchlorate level in our sample was
slightly higher than the mean perchlorate level in U.S. adults
over 20 years of age in 2013–2014 reported by the Center for
Disease Control and Prevention (CDC) (3.1lg/L vs. 2.53lg/L)
(36). The median thiocyanate level in our sample was almost
one-half of the mean thiocyanate level in U.S. adults over 20
years of age in 2013–2014 reported by the CDC (514lg/L vs.
1060lg/L) (36). This is likely because of the small number of
smokers in our sample, and our mean is more in line with the
mean thiocyanate level of 773lg/L (0.773mg/L) found in
nonsmoking adults in 2013–2014 by the CDC.
Spot urine iodine, perchlorate, and thiocyanate concen-
trations were all significantly positively correlated with each
other, likely due to co-contamination from common exposure
routes. Interestingly, the correlation between thiocyanate and
iodine became stronger when assessed in the subset of lac-
tating women with UIC <100lg/L. There may be underlying
behavioral differences affecting the correlations between
Table 4. Multivariable Regression Analysis
Predicting Spot Urine Thiocyanate Levels
Using Supplemental Baby Formula
as a Categorical Variable (p < 0.0001, R2 = 0.22)
Covariates Estimate (SE) p-Value
Intercept 1609.5 (175.7) <0.0001
Race/ethnicity 0.013
Black -213.7 (65.1) 0.001
Hispanic -129.9 (86.8) 0.14
Asian -20.5 (77.3) 0.79
Native American -279.0 (188.2) 0.14
Other -227.1 (118.5) 0.06
Mother’s age 0.37 (4.76) 0.94
Marital status 0.03
Married -200.0 (64.6) 0.002
Divorced -119.7 (102.0) 0.24
Widowed -387.2 (438.9) 0.38
Other -333.5 (180.0) 0.06
Highest education level 0.98
Vocation/trade school -45.0 (82.2) 0.58
2-year college -44.6 (93.6) 0.63
4-year college -32.6 (84.8) 0.70
Graduate school or higher -23.5 (83.9) 0.78
MVI use – no 90.6 (57.2) 0.12
Smoking – no -806.8 (144.7) <0.0001
Supplemental baby formula use 1.00
<12 ounces/day -2.5 (53.8) 0.96
‡12 ounces/day 0.69 (82.1) 0.99
Spot urine perchlorate level 5.7 (3.7) 0.12
White race/ethnicity, never married marital status, highest education
level of high school or less, MVI use, smoking, and no baby formula
use were used as the reference groups.
Table 5. Multivariable Regression Analysis
Predicting Spot Urine Thiocyanate Levels
Using Supplemental Baby Formula
as a Dichotomous Variable (p < 0.0001, R2 = 0.22)
Covariates Estimate (SE) p-Value
Intercept 1608.1 (169.6) <0.0001
Race/ethnicity 0.013
Black -213.7 (65.0) 0.001
Hispanic -130.0 (86.6) 0.13
Asian -20.9 (76.5) 0.78
Native American -277.7 (185.0) 0.13
Other -227.5 (117.9) 0.05
Mother’s age -0.003 (0.004) 0.94
Marital status 0.03
Married -200.2 (64.3) 0.002
Divorced -119.6 (101.8) 0.24
Widowed -387.8 (438.0) 0.38
Other -333.1 (179.5) 0.06
Highest education level 0.98
Vocation/trade school -45.0 (82.1) 0.58
2-year college -44.4 (93.3) 0.63
4-year college -32.5 (84.6) 0.70
Graduate school or higher -23.3 (83.7) 0.78
MVI use – no 90.6 (57.1) 0.11
Smoking – no -807.1 (114.3) <0.0001
Supplement baby formula use – no 1.86 (51.5) 0.97
Spot urine perchlorate level 5.7 (3.7) 0.12
White race/ethnicity, never married marital status, highest education
level of high school or less, MVI use, smoking, and no baby formula
use were used as the reference groups.
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UIC and urinary thiocyanate levels. For example, one subject
had a very highUIC of 2140lg/L and a high urinary thiocyanate
level of 2230lg/L, suggesting a possible unifying environ-
mental exposure or possibly due to concentration of urine.
There were no significant predictors for UIC, although
race/ethnicity was a significant predictor of UIC <100 lg/L
in one multivariable analysis. There were no significant
predictors of urinary perchlorate levels. Smoking was one
of the significant predictors of urinary thiocyanate levels in
our multivariable analyses, as expected. As perchlorate and
thiocyanate are inhibitors of NIS, they were not included in
the multivariable models predicting UIC or low UIC.
Normal UICs do not exclude the possibility that perchlo-
rate or thiocyanate may still impair iodine uptake into the
thyroid gland leading to thyroid dysfunction (29), or into
lactating mammary glands leading to inadequate iodine
nutrition for breastfed infants (32,33). In the presence of
underlying iodine deficiency with low thyroidal iodine
storage, the effects of perchlorate or thiocyanate exposure
on thyroid function or breastmilk iodine content may be
greater. Given the findings of an increasing proportion of
women of reproductive age with UIC <50 lg/L (7) and high
proportions of pregnant or lactating women with UIC
<100 lg/L as seen in the NHANES data (7) and in the
present study, U.S. pregnant or lactating women and
breastfed infants remain particularly vulnerable to the ad-
verse effects of low-level environmental perchlorate and
thiocyanate exposures.
Limitations of this study include a lack of information re-
garding dietary habits and thyroidal iodine saturation status. A
spot UIC does not reflect thyroidal iodine status since the thyroid
may have adequate iodine storage even though UIC is low.
However, obtaining a nuclear scan to assess thyroidal iodine
uptake would have been extremely difficult, as our subjects were
all lactating mothers. Therefore, we used UIC to assess
population-level iodine sufficiency using the threshold re-
commended by theWHO.Another limitation of this study is lack
of measurement of urinary creatinine levels as a marker of urine
dilution. However, UIC without correction with urinary creati-
nine level is deemed to be sufficient in assessing population-level
iodine status by the WHO and we measured iodine, perchlorate,
and thiocyanate from the same urine sample to minimize po-
tential confounding by dilution. Strengths include the sample size
and the ethnic diversity of our study population, with 37% non-
Hispanic whites, 31% non-Hispanic blacks, and 11% Hispanic.
In summary, this study provides novel data assessing the
current status of iodine nutrition among U.S. lactating wo-
men, in direct line with one of the charges by the recent
American Thyroid Association guidelines for the diagnosis
and management of thyroid disease in pregnancy and the
postpartum period (10). These findings show that population-
level iodine sufficiency was demonstrated from three distinct
U.S. geographic regions, and iodine nutrition among U.S. lac-
tating women is comparable across these regions. Median uri-
nary perchlorate and thiocyanate concentrations were similar
among the three sites. Although the U.S. Environmental Pro-
tection Agency announced in February 2011 that perchlorate
regulation of drinking water will be considered (37), such
measures have not yet been implemented, and discussions to do
so continue to be in progress (38). Given ubiquitous exposure to
low-level environmental perchlorate and thiocyanate in our
sample population, adequate iodine nutrition should be em-
phasized in lactating women to provide optimal iodine nutrition
for their breastfed infants.
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